169 related articles for article (PubMed ID: 30610091)
1. Refining the spinobulbar muscular atrophy phenotype by quantitative MRI and clinical assessments.
Dahlqvist JR; Oestergaard ST; Poulsen NS; Thomsen C; Vissing J
Neurology; 2019 Feb; 92(6):e548-e559. PubMed ID: 30610091
[TBL] [Abstract][Full Text] [Related]
2. Disease progression and outcome measures in spinobulbar muscular atrophy.
Dahlqvist JR; Fornander F; de Stricker Borch J; Oestergaard ST; Poulsen NS; Vissing J
Ann Neurol; 2018 Nov; 84(5):754-765. PubMed ID: 30255951
[TBL] [Abstract][Full Text] [Related]
3. Whole-Body Muscle Magnetic Resonance Imaging in 81 Patients with Spinal and Bulbar Muscular Atrophy: A Prospective Study.
Kim H; Seo I; Kang M; Park JM; Seok HY; Kim S; Park JS
Ann Neurol; 2024 Mar; 95(3):596-606. PubMed ID: 38054838
[TBL] [Abstract][Full Text] [Related]
4. Muscle contractility in spinobulbar muscular atrophy.
Dahlqvist JR; Oestergaard ST; Poulsen NS; Knak KL; Thomsen C; Vissing J
Sci Rep; 2019 Mar; 9(1):4680. PubMed ID: 30886222
[TBL] [Abstract][Full Text] [Related]
5. Fat Replacement of Paraspinal Muscles with Aging in Healthy Adults.
Dahlqvist JR; Vissing CR; Hedermann G; Thomsen C; Vissing J
Med Sci Sports Exerc; 2017 Mar; 49(3):595-601. PubMed ID: 27741218
[TBL] [Abstract][Full Text] [Related]
6. Severe paraspinal muscle involvement in facioscapulohumeral muscular dystrophy.
Dahlqvist JR; Vissing CR; Thomsen C; Vissing J
Neurology; 2014 Sep; 83(13):1178-83. PubMed ID: 25142899
[TBL] [Abstract][Full Text] [Related]
7. Skeletal muscle MRI differentiates SBMA and ALS and correlates with disease severity.
Klickovic U; Zampedri L; Sinclair CDJ; Wastling SJ; Trimmel K; Howard RS; Malaspina A; Sharma N; Sidle K; Emira A; Shah S; Yousry TA; Hanna MG; Greensmith L; Morrow JM; Thornton JS; Fratta P
Neurology; 2019 Aug; 93(9):e895-e907. PubMed ID: 31391248
[TBL] [Abstract][Full Text] [Related]
8. Fat fraction distribution in lower limb muscles of patients with CMT1A: A quantitative MRI study.
Bas J; Ogier AC; Le Troter A; Delmont E; Leporq B; Pini L; Guye M; Parlanti A; Lefebvre MN; Bendahan D; Attarian S
Neurology; 2020 Apr; 94(14):e1480-e1487. PubMed ID: 31980579
[TBL] [Abstract][Full Text] [Related]
9. MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients.
Andersen G; Dahlqvist JR; Vissing CR; Heje K; Thomsen C; Vissing J
J Neurol; 2017 Mar; 264(3):438-447. PubMed ID: 28000006
[TBL] [Abstract][Full Text] [Related]
10. The 6-minute walk test, motor function measure and quantitative thigh muscle MRI in Becker muscular dystrophy: A cross-sectional study.
Fischer D; Hafner P; Rubino D; Schmid M; Neuhaus C; Jung H; Bieri O; Haas T; Gloor M; Fischmann A; Bonati U
Neuromuscul Disord; 2016 Jul; 26(7):414-22. PubMed ID: 27209345
[TBL] [Abstract][Full Text] [Related]
11. Lower extremity muscle pathology in myotonic dystrophy type 1 assessed by quantitative MRI.
Heskamp L; van Nimwegen M; Ploegmakers MJ; Bassez G; Deux JF; Cumming SA; Monckton DG; van Engelen BGM; Heerschap A
Neurology; 2019 Jun; 92(24):e2803-e2814. PubMed ID: 31118244
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of inflammatory lesions over 2 years in facioscapulohumeral muscular dystrophy.
Dahlqvist JR; Poulsen NS; Østergaard ST; Fornander F; de Stricker Borch J; Danielsen ER; Thomsen C; Vissing J
Neurology; 2020 Sep; 95(9):e1211-e1221. PubMed ID: 32611642
[TBL] [Abstract][Full Text] [Related]
13. Tongue pressure as a novel biomarker of spinal and bulbar muscular atrophy.
Mano T; Katsuno M; Banno H; Suzuki K; Suga N; Hashizume A; Araki A; Watanabe H; Tanaka S; Yamamoto M; Sobue G
Neurology; 2014 Jan; 82(3):255-62. PubMed ID: 24353334
[TBL] [Abstract][Full Text] [Related]
14. Axial muscle involvement in patients with limb girdle muscular dystrophy type R9.
Revsbech KL; Rudolf K; Sheikh AM; Khawajazada T; de Stricker Borch J; Dahlqvist JR; Løkken N; Witting N; Vissing J
Muscle Nerve; 2022 Apr; 65(4):405-414. PubMed ID: 35020210
[TBL] [Abstract][Full Text] [Related]
15. Skeletal Muscle Magnetic Resonance Biomarkers in GNE Myopathy.
Liu CY; Yao J; Kovacs WC; Shrader JA; Joe G; Ouwerkerk R; Mankodi AK; Gahl WA; Summers RM; Carrillo N
Neurology; 2021 Feb; 96(5):e798-e808. PubMed ID: 33219145
[TBL] [Abstract][Full Text] [Related]
16. Associations of thigh muscle fat infiltration with isometric strength measurements based on chemical shift encoding-based water-fat magnetic resonance imaging.
Inhuber S; Sollmann N; Schlaeger S; Dieckmeyer M; Burian E; Kohlmeyer C; Karampinos DC; Kirschke JS; Baum T; Kreuzpointner F; Schwirtz A
Eur Radiol Exp; 2019 Nov; 3(1):45. PubMed ID: 31748839
[TBL] [Abstract][Full Text] [Related]
17. Progressive fat replacement of muscle contributes to the disease mechanism of patients with single, large-scale deletions of mitochondrial DNA.
Hedermann G; Dahlqvist JR; Løkken N; Vissing CR; Knak KL; Andersen LK; Thomsen C; Vissing J
Neuromuscul Disord; 2018 May; 28(5):408-413. PubMed ID: 29567350
[TBL] [Abstract][Full Text] [Related]
18. Muscle MRI findings of X-linked spinal and bulbar muscular atrophy.
Hamano T; Mutoh T; Hirayama M; Kawamura Y; Nagata M; Fujiyama J; Kuriyama M
J Neurol Sci; 2004 Jul; 222(1-2):93-7. PubMed ID: 15240202
[TBL] [Abstract][Full Text] [Related]
19. Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne muscular dystrophy.
Mankodi A; Bishop CA; Auh S; Newbould RD; Fischbeck KH; Janiczek RL
Neuromuscul Disord; 2016 Oct; 26(10):650-658. PubMed ID: 27593185
[TBL] [Abstract][Full Text] [Related]
20. Selection Approach to Identify the Optimal Biomarker Using Quantitative Muscle MRI and Functional Assessments in Becker Muscular Dystrophy.
van de Velde NM; Hooijmans MT; Sardjoe Mishre ASD; Keene KR; Koeks Z; Veeger TTJ; Alleman I; van Zwet EW; Beenakker JM; Verschuuren JJGM; Kan HE; Niks EH
Neurology; 2021 Aug; 97(5):e513-e522. PubMed ID: 34162720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
